Evommune raises $150M in an IPO during the federal shutdown using a securities law workaround, signaling a new path for ...
Pfizer prepares a sweetened bid for obesity drugmaker Metsera, signaling a major strategic shift in the high-stakes pharmaceutical M&A landscape The Silicon Review.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback